GMP Law Substitute’s Philips CPAP Class Action

Sleep apnea and other sleep-related breathing conditions affect thousands of Australians, many of whom rely on CPAP machines to maintain open airways while they sleep. Philips Respironics, a top manufacturer of these devices, began a global corrective action for its defective products.

In July 2021, Philips Australia and New Zealand announced an urgent product recall for specific Philips Continuous Positive Airway Pressure (CPAP), BiLevel Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators.

According to the TGA, if the products are left unfixed, the foam used in the blower box to reduce the noise of the machine may degrade into particles and release certain chemicals or gases which may be inhaled or ingested.

Prolonged and repeated usage of the affected machines may result in a range of symptoms including headaches, nausea, inflammatory responses, asthma, and potentially even carcinogenic effects.

The class action seeks to compensate those affected for pain and suffering, and economic loss.